REDucing Delays In Aneurysmal Subarachnoid Haemorrhage: The REDDISH Study
Funder
National Health and Medical Research Council
Funding Amount
$436,022.00
Summary
Aneurysmal subarachnoid haemorrhage (aSAH) is a rare form of stroke that kills at least 30% of sufferers within 1 month. Outcome can be improved through quickly receiving medical care but many people do not and this likely contributes to the poor outcomes. The REDucing Delays In Subarachnoid Haemorrhage (REDDISH) study will look at cases of aSAH across Tasmanian and Victoria so that we can understand the factors that contribute to delays in treatment and ultimately improve outcomes.
Outcomes After Serious Injury: What Is The Recovery Trajectory And How Do The Priorities For Treatment And Disability Services Change Over Time?
Funder
National Health and Medical Research Council
Funding Amount
$766,630.00
Summary
Traumatic injury is a significant contributor to global disease burden, with serious injury commonly resulting in disability and profound costs to the individual, family and society. This population-based project will describe the long term consequences of injury and recovery experiences of more than 2500 seriously injured patients. This longitudinal study will use quantitative and qualitative data to provide a comprehensive overview of patient outcomes and experiences in the first 5-years after ....Traumatic injury is a significant contributor to global disease burden, with serious injury commonly resulting in disability and profound costs to the individual, family and society. This population-based project will describe the long term consequences of injury and recovery experiences of more than 2500 seriously injured patients. This longitudinal study will use quantitative and qualitative data to provide a comprehensive overview of patient outcomes and experiences in the first 5-years after injury.Read moreRead less
The Incidence And Outcomes Of Chronic Kidney Disease Amongst Indigenous Australians
Funder
National Health and Medical Research Council
Funding Amount
$140,120.00
Summary
The aim of this body of work is to improve understanding of the incidence and outcomes of chronic kidney disease for Indigenous Australians, in order to try to better predict outcomes and guide clinical and policy-level decision making.
Chronic Kidney Disease In Indigenous Australians: Using Existing Data To Improve Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$303,014.00
Summary
Indigenous Australians not only suffer from a high burden of kidney disease, but also have poorer disease outcomes compared to non-Indigenous Australians. My research program is focused on improving outcomes for Indigenous Australians with kidney disease by using existing health care data to work out where and why their outcomes are poor within the health care system. It will enable us to identify ways to improve health care systems for Indigenous Australians.
Large-scale Epidemiology, Chronic Disease And Disadvantaged Populations: Evidence And Translation
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
Nationally and internationally, we face an increasing burden of chronic disease and health care costs. Health risk factors and premature ill-health are increasingly concentrated in the disadvantaged. A large proportion of the chronic disease burden is preventable through better evidence and implementation. This application is to conduct innovative large-scale research on Indigenous health, chronic disease and the health of disadvantaged populations, including work on implementation of solutions.
Increasing Global And National Knowledge About Illicit Drug Use, Harms And Effective Interventions
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
This Fellowship aims to increase global and national knowledge about drug use and related harms, and interventions to prevent harm and improve public health. It will create new knowledge that will be used by UN and international agencies, and national governments, to monitor changes in drug use and harms, and guide policy and planning for drug treatment and harm reduction services.